Series B · Biotech · London, United Kingdom · Founded 2018 · 51–200 employees
Causaly provides an enterprise AI platform designed for biomedical research and life sciences R&D by integrating scientific knowledge graphs with generative AI and agentic workflow automation. The system analyzes tens of millions of scientific publications, clinical trial records, and internal datasets to find cause-and-effect relationships in disease biology. The startup has raised a total of $93 million in equity funding, including a $60 million Series B round led by ICONIQ Growth. Its technology is backed by prominent industry leaders, including former Johnson & Johnson CEO Alex Gorsky and Datadog CEO Olivier Pomel.
No open roles listed right now.